Neumora Therapeutics (NMRA) Cash from Investing Activities (2022 - 2026)
Neumora Therapeutics' Cash from Investing Activities was $71,000 in Q1 2026, down 99.8% from $44.16 million a year earlier and down 99.8% from the prior quarter.
Powered by 
Analysis
Neumora Therapeutics (NMRA) Cash from Investing Activities (2022 - 2026) Analysis & Trends
For FY2025, Cash from Investing Activities at Neumora Therapeutics came in at $168.52 million.
- In earlier years, Cash from Investing Activities was -$70.56 million in FY2024, $64.39 million in FY2023 and -$168.01 million in FY2022.
- The Q1 2026 figure marks the lowest quarterly Cash from Investing Activities since Q4 2024.
- Compared with a year earlier, Cash from Investing Activities was higher in two of the last five quarters, with growth averaging 84.7%.
- Per Business Quant data, NMRA's Cash from Investing Activities in the three quarters before Q1 2026 was $42.65 million (Q4 2025), $51.32 million (Q3 2025) and $30.4 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | -15.40 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | -1.11 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | -1.20 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | -5.60 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.11 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -2.91 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | -569.00 Mn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -10.35 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 2.11 Bn |
| 10 | Neumora Therapeutics | 103.34 Mn | 103.34 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 71,000.00 |
| Dec 31, 2025 | 42.65 Mn |
| Sep 30, 2025 | 51.32 Mn |
| Jun 30, 2025 | 30.40 Mn |
| Mar 31, 2025 | 44.16 Mn |
| Dec 31, 2024 | -98.80 Mn |
| Sep 30, 2024 | 156.99 Mn |
| Jun 30, 2024 | 21.26 Mn |
| Mar 31, 2024 | -150.00 Mn |
| Dec 31, 2023 | 13.68 Mn |
| Sep 30, 2023 | 23.82 Mn |
| Jun 30, 2023 | 24.08 Mn |
| Mar 31, 2023 | 2.82 Mn |
| Dec 31, 2022 | -8.03 Mn |
API Access
Neumora Therapeutics Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=NMRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "NMRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=NMRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();